The abstract is read at the publisher; the summary is JClub's.
HMGB1 directly activates BAP1 transcription in mesothelioma models, and HMGB1 loss significantly reduces BAP1 expression while HMGB1 overexpression increases BAP1 mRNA and protein levels.
- Why it matters: BAP1 and HMGB1 alterations are linked to mesothelioma, but the mechanism controlling BAP1 expression was unknown, limiting therapeutic targeting of this pathway.
- What they did: Using Hmgb1 knock-out mouse mesothelioma models, primary fibroblasts from carriers of pathogenic heterozygous germline BAP1 mutations, and mesothelioma cell lines, the study tested HMGB1 effects on BAP1 and showed promoter binding and transcriptional activation.
- The result: HMGB1-driven BAP1 overexpression promoted mesothelioma cell proliferation, migration, and invasion, supporting the HMGB1–BAP1 axis as a therapy target and offering a mechanistic rationale for improved survival in patients with somatic BAP1 inactivating mutations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.